EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Motivation, barriers, and willingness to participate in clinical trials for novel cancer treatments among the Vietnamese population

Pol Van Nguyen, Thanh Thi Thuy Tran iD, Hieu Thi Thanh Nguyen, Hien Thi Bich Tran, Van Nguyen Thanh Phan, Tram Nguyen Nguyet Luu, Bon Huu Huynh, Khoa Dang Nguyen, Trung Quang Vo

PLOS One · 2025

DOI: 10.1371/journal.pone.0331250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Pol Van Nguyen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Motivation, Neoplasms, Patient Participation. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Novel therapeutic approaches are actively explored and evaluated, but applying these innovations to practice depends critically on the recruitment of volunteers for clinical trials. This study aimed to assess the motivations, barriers, and willingness of the general population in Vietnam to participate in clinical trials for novel cancer treatments.

Methods

This analytical cross-sectional research involved the distribution of self-administered online and printed questionnaires to residents across central and southern Vietnam in December 2024. A structured 23-item questionnaire was developed based on a literature review of studies from the UK, US, and Germany. Items were culturally adapted for Vietnam and translated using a WHO-adapted four-step process, including forward translation, expert panel review, cognitive interviews with 25 participants, and final revision. Face and content validity were assessed during this process. Logistic regression analysis was conducted to determine the factors associated with the respondents’ willingness to participate in the aforementioned clinical trials.

Results

The questionnaires were completed by 851 participants, with the majority aged 40–50 years (30.3%). The respondents also indicated a preference for treatments with prior clinical use and coverage by health insurance (65.6%). The primary motivation for participation was intensive monitoring of conditions (83.7%). The most frequently cited barrier were concerns regarding the high risk associated with less-tested treatments (74.1%). A total of 33.6% expressed a willingness to participate in clinical trials, but fewer (18.9%) were willing to allow such involvement for their children or other family members. Finally, Kinh ethnicity, good health, and positive attitudes toward novel cancer treatments were significantly associated with an increased willingness to participate in clinical trials (p < 0.05).

Conclusion

This study provides critical insights into the motivation of and barriers to participation in clinical trials for novel cancer treatments. Addressing barriers and promoting motivations can contribute to supporting cancer clinical trial conductions and then improving cancer treatment effectiveness in Vietnam.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicMotivationNeoplasmsPatient ParticipationAdultAgedFemaleHumansMaleMiddle AgedYoung AdultCross-Sectional StudiesSoutheast Asian PeopleSurveys and QuestionnairesVietnam

Autor:innen und Institutionen

  • Faculty of Pharmacy, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.
  • Social, Economic and Administrative Pharmacy (SEAP) Graduate Program, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
  • Faculty of Medicine, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.
  • Faculty of Pharmacy, Hue University of Medicine and Pharmacy, Hue University, Hue, Vietnam.
  • Department of Pharmacology - Clinical Pharmacy, Da Nang University of Medical Technology and Pharmacy, Danang, Vietnam.
  • Interventional Cardiology Department, Gia Dinh People Hospital, Ho Chi Minh City, Vietnam.

ORCID-Profile: Thanh Thi Thuy Tran

Zitieren

APA

Van Nguyen, P., Tran, T. T. T., Nguyen, H. T. T., Tran, H. T. B., Phan, V. N. T., Luu, T. N. N., Huynh, B. H., Nguyen, K. D., & Vo, T. Q. (2025). Motivation, barriers, and willingness to participate in clinical trials for novel cancer treatments among the Vietnamese population. PLOS One. https://doi.org/10.1371/journal.pone.0331250

Vancouver

Van Nguyen P, Tran TTT, Nguyen HTT, Tran HTB, Phan VNT, Luu TNN, et al. Motivation, barriers, and willingness to participate in clinical trials for novel cancer treatments among the Vietnamese population. PLOS One. 2025. doi:10.1371/journal.pone.0331250

BibTeX
@article{VanNguyen2025,
  author = {Van Nguyen, Pol and Tran, Thanh Thi Thuy and Nguyen, Hieu Thi Thanh and Tran, Hien Thi Bich and Phan, Van Nguyen Thanh and Luu, Tram Nguyen Nguyet and Huynh, Bon Huu and Nguyen, Khoa Dang and Vo, Trung Quang},
  title = {Motivation, barriers, and willingness to participate in clinical trials for novel cancer treatments among the Vietnamese population},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0331250}
}
Kostenlos starten →